Hotaling Investment Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Hotaling Investment Management's IDXX Position: Q2 2022 in Review
Hotaling Investment Management sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 3,384 shares — an estimated $1.85M sold.
Hotaling Investment Management first reported a position in IDXX in Q1 2019 and held it in 13 quarters. The position peaked at $2.33M in Q4 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.
- Hotaling Investment Management reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
- Hotaling Investment Management sold 3,384 Idexx Laboratories shares in Q2 2022, an estimated $1.85M.
- Hotaling Investment Management first reported a position in Idexx Laboratories in Q1 2019 and held it in 13 quarters.
- Hotaling Investment Management's Idexx Laboratories position peaked at $2.33M in Q4 2021.
- 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.
Based on Hotaling Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.